Role of 5-HT1A and 5-HT7 receptors in the facilitatory response induced by 8-OH-DPAT on learning consolidation

被引:41
作者
Meneses, A [1 ]
Terrón, JA [1 ]
机构
[1] IPN, CINVESTAV, Dept Farmacol, Mexico City 14000, DF, Mexico
关键词
autoshaping; 8-OH-DPAT; 5-HT7; receptor; 5-HT2 receptor subtypes; learning consolidation;
D O I
10.1016/S0166-4328(00)00378-8
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
The present study further explored the mechanisms involved in the facilitatory effect induced by (+/-)-8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) on learning consolidation. For this purpose, we analyzed in parallel the effects of LY215830 and ritanserin, two 5-HT2 receptor antagonists with high affinity for the 5-HT7 receptor, and WAY100635, a selective 5-HT1A receptor antagonist, on the facilitatory effect induced by 8-OH-DPAT on learning consolidation. We also determined whether LY215840 and/or ritanserin could be beneficial in restoring a deficient learning condition. Using the model of autoshaping task, post-training injection of LY215840 or WAY100635 had no effect on learning consolidation. However, both drugs abolished the enhancing effect of 8-OH-DPAT, with LY215810 being slightly more effective than WAY100635 in this respect. Ritanserin produced an increase in performance by itself and also abolished the effect of 8-OH-DPAT. Remarkably. selective blockade of 5-HT2A and 5-HT2B-2C receptors with MDL100907 and SB200646, respectively, railed to alter the 8-OH-DPAT effect. LY215840 and ritanserin, at the doses that inhibited the 8-OH-DPAT-induced response, reversed the learning deficits induced by scopolamine and dizocilpine. The present results suggest that the enhancing effect produced by 8-OH-DPAT on learning consolidation involves activation of 5-HT1A receptors and an additional mechanism, probably related to the 5-HT7 receptor. Blockade of 5-HT2 receptors, and perhaps of 5-HT7 receptors as well, may provide some benefit in reversing learning deficits associated with decreased cholinergic and/or glutamatergic neurotransmission. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:21 / 28
页数:8
相关论文
共 62 条
[1]  
Adham N, 1998, J PHARMACOL EXP THER, V287, P508
[2]  
[Anonymous], CNS DRUG REV
[3]  
[Anonymous], CNS DRUG REV
[4]  
[Anonymous], STEROTONINERGIC NEUR
[5]   A review of central 5-HT receptors and their function [J].
Barnes, NM ;
Sharp, T .
NEUROPHARMACOLOGY, 1999, 38 (08) :1083-1152
[6]   THE PHARMACOLOGY AND DISTRIBUTION OF HUMAN 5-HYDROXYTRYPTAMINE(2B) (5-HT2B) RECEPTOR GENE-PRODUCTS - COMPARISON WITH 5-HT2A AND 5-HT2C RECEPTORS [J].
BONHAUS, DW ;
BACH, C ;
DESOUZA, A ;
SALAZAR, FHR ;
MATSUOKA, BD ;
ZUPPAN, P ;
CHAN, HW ;
EGLEN, RM .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 (04) :622-628
[7]   CHANGES IN EXPLORATORY ACTIVITY FOLLOWING STIMULATION OF HIPPOCAMPAL 5-HT1A AND 5-HT1B RECEPTORS IN THE RAT [J].
BUHOT, MC ;
NAILI, S .
HIPPOCAMPUS, 1995, 5 (03) :198-208
[8]   WAY 100635, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by blockade of hippocampal NMDA receptors [J].
Carli, M ;
Silva, S ;
Balducci, C ;
Samanin, R .
NEUROPHARMACOLOGY, 1999, 38 (08) :1165-1173
[9]   SEROTONERGIC MODULATION OF CHOLINERGIC FUNCTION IN THE CENTRAL-NERVOUS-SYSTEM - COGNITIVE IMPLICATIONS [J].
CASSEL, JC ;
JELTSCH, H .
NEUROSCIENCE, 1995, 69 (01) :1-41
[10]  
Cushing DJ, 1996, J PHARMACOL EXP THER, V277, P1560